[ACCESSWIRE]
LOS ANGELES, CA / ACCESSWIRE / November 21, 2017 / Medovex Corporation (OTCQB: MDVX), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome related to chronic back pain, a non-addictive, non-opioid drug alternative capable of restoring a patient to a more normal and active lifestyle, today announced that it will be presenting at the 10th annual LD Micro Main Event on Tuesday, December 5, at 2:30PM PST / 5:30 PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Jesse Crowne, Co-Executive Chairman of Medovex, will be presenting, as well as meeting with investors.
The LD Micro Main Event is the largest independent conference for small/micro-cap companies and will feature 250 names presenting to an audience of over 1,000 attendees. In addition, there will be a variety of speakers/panelists discussing topics of interest to investors and issuers, along with coordinate evening events.
A webcast of the presentation is available at the Company's website under the IR section and at the following link: http://wsw.com/webcast/ldmicro13/mdvx/.
View Medovex's profile here: http://www.ldmicro.com/profile/MDVX.
News Compliments of ACCESSWIRE.
About Medovex
Medovex was formed to acquire and develop a diversified portfolio of potentially groundbreaking medical technology products. Criteria for selection include those products with potential for significant improvement in the quality of patient care combined with cost-effectiveness. The Company's first pipeline product, the DenerveX System, is intended to provide long-lasting relief from pain associated with facet joint syndrome at significantly less cost than currently available options. To learn more about Medovex Corp., visit www.medovex.com.
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into several influential conferences annually.
In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector.
For those interested in attending, please contact David Scher at [email protected] or visit www.ldmicro.com/events for more information.
Contact Information
Medovex Corp.
Jason Assad
470-505-9905
[email protected]
GLOBAL MEDIA CONTACTS
David Schull
Russo Partners LLC
212-845-4271 (office)
858-717-2310 (mobile)
[email protected]
Karen Chase
Russo Partners LLC
646-942-5627 (office)
917-547-0434 (mobile)
[email protected]
SOURCE: Medovex Corp.
